A. Weiskopf

发表

Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additive for direct characterization of size variants of monoclonal antibodies.

Li Zang, Chong-feng Xu, A. Weiskopf, 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis.

Tony Lubiniecki, M. Rossi, P. Garidel, 2015, Biologicals : journal of the International Association of Biological Standardization.

Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy.

Tony Lubiniecki, M. Rossi, P. Garidel, 2015, Journal of pharmaceutical sciences.

1α,25‐Dihydroxy‐3‐epi‐vitamin D3: In vivo metabolite of 1α,25‐dihydroxyvitamin D3 in rats

M. Uskoković, P. Vouros, W. Okamura, 1999 .

Technical Decision-Making with Higher Order Structure Data: Detecting Reversible Concentration-Dependent Self-Association in a Monoclonal Antibody and a Preliminary Investigation to Eliminate It.

Damian J. Houde, G. Bou-Assaf, A. Weiskopf, 2015, Journal of pharmaceutical sciences.

Electrospray ionization-ion trap mass spectrometry for structural analysis of complex N-linked glycoprotein oligosaccharides.

D. Harvey, P. Vouros, A. Weiskopf, 1998, Analytical chemistry.

Isolation and identification of 1α‐hydroxy‐3‐epi‐vitamin D3, a potent suppressor of parathyroid hormone secretion

Alex J. Brown, M. Uskoković, P. Vouros, 2005, Journal of cellular biochemistry.

Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed.

M. Uskoković, A. Norman, P. Vouros, 1999, Bone.

Differentiation-Related Pathways of 1α,25-Dihydroxycholecalciferol Metabolism in Human Colon Adenocarcinoma-Derived Caco-2 Cells: Production of 1α,25-Dihydroxy-3epi-cholecalciferol

H. Cross, P. Vouros, M. Peterlik, 1998 .

Metabolism of selective 20-epi-vitamin D3 analogs in rat osteosarcoma UMR-106 cells: Isolation and identification of four novel C-1 fatty acid esters of 1α,25-dihydroxy-16-ene-20-epi-vitamin D3

M. Uskoković, P. Vouros, G. Reddy, 2017, Steroids.

Examination of structurally selective derivatization of vitamin D(3) analogues by electrospray mass spectrometry.

L. Binderup, M. White, P. Vouros, 2001, Journal of mass spectrometry : JMS.

Rapid Conformational Analysis of Protein Drugs in Formulation by Hydrogen/Deuterium Exchange Mass Spectrometry.

M. van de Weert, Damian J. Houde, G. Bou-Assaf, 2016, Journal of pharmaceutical sciences.

Differentiation-related pathways of 1 alpha,25-dihydroxycholecalciferol metabolism in human colon adenocarcinoma-derived Caco-2 cells: production of 1 alpha,25-dihydroxy-3epi-cholecalciferol.

H. Cross, P. Vouros, M. Peterlik, 1998, Experimental cell research.

1α,25-Dihydroxy-16-ene-23-yne-vitamin D3 and 1α,25-Dihydroxy-16-ene-23-yne-20-epi-vitaminD3: Analogs of 1α,25-Dihydroxyvitamin D3 That Resist Metabolism through the C-24 Oxidation Pathway Are Metabolized through the C-3 Epimerization Pathway

M. Uskoković, P. Vouros, G. Reddy, 2000 .

Enhanced biological activity of 1α,25-dihydroxy-20-epi-vitamin D3, the C-20 epimer of 1α,25-dihydroxyvitamin D3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity

L. Binderup, S. Peleg, P. Vouros, 1999, The Journal of Steroid Biochemistry and Molecular Biology.

Tissue specific metabolism of 1α,25‐dihydroxy‐20‐epi‐vitamin D3 into new metabolites with significant biological activity: Studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8)

S. Peleg, P. Vouros, G. Reddy, 2001, Journal of cellular biochemistry.

Characterization of oligosaccharide composition and structure by quadrupole ion trap mass spectrometry.

D. Harvey, P. Vouros, P Vouros, 1997, Rapid communications in mass spectrometry : RCM.

Analysis of dynamic changes in the proteome of a Bcl‐XL overexpressing Chinese hamster ovary cell culture during exponential and stationary phases

W. Hancock, V. Janakiraman, Li Zang, 2012, Biotechnology progress.

Using X-ray fluorescence to measure inorganics in biopharmaceutical raw materials

J. Mondia, M. Lanan, A. Weiskopf, 2015 .